145 related articles for article (PubMed ID: 24631466)
1. Homocysteine and metabolic syndrome: from clustering to additional utility in prediction of coronary heart disease.
Esteghamati A; Hafezi-Nejad N; Zandieh A; Sheikhbahaei S; Ebadi M; Nakhjavani M
J Cardiol; 2014 Oct; 64(4):290-6. PubMed ID: 24631466
[TBL] [Abstract][Full Text] [Related]
2. Associations of Metabolic Syndrome with Total Testosterone and Homocysteine Levels in Male Korean Workers.
Sung SH; Kim NH; Hong SP; Lee JK; Choi SJ
Endocrinol Metab (Seoul); 2019 Jun; 34(2):158-168. PubMed ID: 31257744
[TBL] [Abstract][Full Text] [Related]
3. The Homocysteine and Metabolic Syndrome: A Mendelian Randomization Study.
Lee HS; In S; Park T
Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371949
[TBL] [Abstract][Full Text] [Related]
4. High plasma homocysteine increases risk of metabolic syndrome in 6 to 8 year old children in rural Nepal.
Yakub M; Schulze KJ; Khatry SK; Stewart CP; Christian P; West KP
Nutrients; 2014 Apr; 6(4):1649-61. PubMed ID: 24763111
[TBL] [Abstract][Full Text] [Related]
5. Associations of a metabolic syndrome severity score with coronary heart disease and diabetes in fasting vs. non-fasting individuals.
DeBoer MD; Filipp SL; Gurka MJ
Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):92-98. PubMed ID: 31662283
[TBL] [Abstract][Full Text] [Related]
6. The relationship between metabolic syndrome, cardiometabolic risk factors and inflammatory markers in a Tehranian population: the Tehran Lipid and Glucose Study.
Zarkesh M; Faam B; Daneshpour MS; Azizi F; Hedayati M
Intern Med; 2012; 51(24):3329-35. PubMed ID: 23257516
[TBL] [Abstract][Full Text] [Related]
7. Impaired coronary blood flow may be related to elevated homocysteine levels in patients with metabolic syndrome.
Alihanoglu YI; Yildiz BS; Özcan EE; Kilic ID; Kuru DS; Taskoylu O; Tanriverdi H; Kaftan HA; Evrengul H
Wien Klin Wochenschr; 2015 Nov; 127(21-22):864-870. PubMed ID: 26377176
[TBL] [Abstract][Full Text] [Related]
8. Hyperhomocysteinemia accompany with metabolic syndrome increase the risk of left ventricular hypertrophy in rural Chinese.
Yu S; Chen Y; Yang H; Guo X; Zheng L; Sun Y
BMC Cardiovasc Disord; 2020 Feb; 20(1):44. PubMed ID: 32013876
[TBL] [Abstract][Full Text] [Related]
9. Risk of coronary heart disease associated with metabolic syndrome and its individual components in Iranian subjects: a matched cohort study.
Esteghamati A; Hafezi-Nejad N; Sheikhbahaei S; Heidari B; Zandieh A; Ebadi M; Nakhjavani M
J Clin Lipidol; 2014; 8(3):279-86. PubMed ID: 24793349
[TBL] [Abstract][Full Text] [Related]
10. Homocysteine and reclassification of cardiovascular disease risk.
Veeranna V; Zalawadiya SK; Niraj A; Pradhan J; Ference B; Burack RC; Jacob S; Afonso L
J Am Coll Cardiol; 2011 Aug; 58(10):1025-33. PubMed ID: 21867837
[TBL] [Abstract][Full Text] [Related]
11. Use of serum homocysteine to predict stroke, coronary heart disease and death in ethnic Chinese. 12-year prospective cohort study.
Sun Y; Chien KL; Hsu HC; Su TC; Chen MF; Lee YT
Circ J; 2009 Aug; 73(8):1423-30. PubMed ID: 19521023
[TBL] [Abstract][Full Text] [Related]
12. [The relationship between serum calcitonin gene-related peptide, sex hormone, homocysteine and coronary artery disease in postmenopausal women].
Wang Z; Guo JX; Wang X; Zhao YM; Hou LF
Zhonghua Nei Ke Za Zhi; 2004 Sep; 43(9):679-81. PubMed ID: 15500781
[TBL] [Abstract][Full Text] [Related]
13. Patterns of clustering of the metabolic syndrome components and its association with coronary heart disease in the Multi-Ethnic Study of Atherosclerosis (MESA): A latent class analysis.
Riahi SM; Moamer S; Namdari M; Mokhayeri Y; Pourhoseingholi MA; Hashemi-Nazari SS
Int J Cardiol; 2018 Nov; 271():13-18. PubMed ID: 29885819
[TBL] [Abstract][Full Text] [Related]
14. Associations between elevated kidney and liver biomarker ratios, metabolic syndrome and all-cause and coronary heart disease (CHD) mortality: analysis of the U.S. National Health and Nutrition Examination Survey (NHANES).
Oye-Somefun A; Kuk JL; Ardern CI
BMC Cardiovasc Disord; 2021 Jul; 21(1):352. PubMed ID: 34311708
[TBL] [Abstract][Full Text] [Related]
15. Clinical usefulness of the metabolic syndrome for the risk of coronary heart disease does not exceed the sum of its individual components in older men and women. The Three-City (3C) Study.
Rachas A; Raffaitin C; Barberger-Gateau P; Helmer C; Ritchie K; Tzourio C; Amouyel P; Ducimetière P; Empana JP
Heart; 2012 Apr; 98(8):650-5. PubMed ID: 22505463
[TBL] [Abstract][Full Text] [Related]
16. Association between high-sensitivity troponin T and cardiovascular risk in individuals with and without metabolic syndrome: The ARIC study.
Pokharel Y; Sun W; Villareal DT; Selvin E; Virani SS; Ndumele CE; Hoogeveen RC; Coresh J; Boerwinkle E; Butler KR; Solomon SD; Pankow JS; Bozkurt B; Ballantyne CM; Nambi V
Eur J Prev Cardiol; 2017 Apr; 24(6):628-638. PubMed ID: 27941157
[TBL] [Abstract][Full Text] [Related]
17. Elevated Homocysteine Levels Are Associated With the Metabolic Syndrome and Cardiovascular Events in Hypertensive Patients.
Catena C; Colussi G; Nait F; Capobianco F; Sechi LA
Am J Hypertens; 2015 Jul; 28(7):943-50. PubMed ID: 25498997
[TBL] [Abstract][Full Text] [Related]
18. The co-existence of elevated high sensitivity C-reactive protein and homocysteine levels is associated with increased risk of metabolic syndrome: A 6-year follow-up study.
Kim J; Pyo S; Yoon DW; Lee S; Lim JY; Heo JS; Lee S; Shin C
PLoS One; 2018; 13(10):e0206157. PubMed ID: 30352089
[TBL] [Abstract][Full Text] [Related]
19. The association of homocysteine with metabolic syndrome in a community-dwelling population: homocysteine might be concomitant with metabolic syndrome.
Wang X; Ye P; Cao R; Yang X; Xiao W; Zhang Y; Bai Y; Wu H
PLoS One; 2014; 9(11):e113148. PubMed ID: 25401978
[TBL] [Abstract][Full Text] [Related]
20. Use of serum homocysteine to predict cardiovascular disease in Korean men with or without metabolic syndrome.
Kang JY; Park IK; Lee JY; Sung SH; Chang YK; Park YK; Choi TI
J Korean Med Sci; 2012 May; 27(5):500-5. PubMed ID: 22563214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
